Mutations in the gene encoding the RNA-binding protein TDP-43 cause amyotrophic lateral sclerosis (ALS), clinically and pathologically indistinguishable from the majority of 'sporadic' cases of ALS, establishing altered TDP-43 function and distribution as a primary mechanism of neurodegeneration. Transgenic mouse models in which TDP-43 is overexpressed only partially recapitulate the key cellular pathology of human ALS, but may also lead to non-specific toxicity. To avoid the potentially confounding effects of overexpression, and to maintain regulated spatio-temporal and cell-specific expression, we generated mice in which an 80 kb genomic fragment containing the intact human TDP-43 locus (either TDP-43 WT or TDP-43 M337V ) and its regulatory regions was integrated into the Rosa26 (Gt (ROSA26)Sor) locus in a single copy. At 3 months of age, TDP-43 M337V mice are phenotypically normal but by around 6 months develop progressive motor function deficits associated with loss of neuromuscular junction integrity, leading to a reduced lifespan. RNA sequencing shows that widespread mis-splicing is absent prior to the development of a motor phenotype, though differential expression analysis reveals a distinct transcriptional profile in pre-symptomatic TDP-43 M337V spinal cords.
Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction 
A B S T R A C T
Mutations in the gene encoding the RNA-binding protein TDP-43 cause amyotrophic lateral sclerosis (ALS), clinically and pathologically indistinguishable from the majority of 'sporadic' cases of ALS, establishing altered TDP-43 function and distribution as a primary mechanism of neurodegeneration. Transgenic mouse models in which TDP-43 is overexpressed only partially recapitulate the key cellular pathology of human ALS, but may also lead to non-specific toxicity. To avoid the potentially confounding effects of overexpression, and to maintain regulated spatio-temporal and cell-specific expression, we generated mice in which an 80 kb genomic fragment containing the intact human TDP-43 locus (either TDP-43 WT or TDP-43 M337V ) and its regulatory regions was integrated into the Rosa26 (Gt (ROSA26)Sor) locus in a single copy. At 3 months of age, TDP-43 M337V mice are phenotypically normal but by around 6 months develop progressive motor function deficits associated with loss of neuromuscular junction integrity, leading to a reduced lifespan. RNA sequencing shows that widespread mis-splicing is absent prior to the development of a motor phenotype, though differential expression analysis reveals a distinct transcriptional profile in pre-symptomatic TDP-43 M337V spinal cords.
Despite the presence of clear motor abnormalities, there was no evidence of TDP-43 cytoplasmic aggregation in vivo at any timepoint. In primary embryonic spinal motor neurons and in embryonic stem cell (ESC)-derived motor neurons, mutant TDP-43 undergoes cytoplasmic mislocalisation, and is associated with altered stress granule assembly and dynamics. Overall, this mouse model provides evidence that ALS may arise through acquired TDP-43 toxicity associated with defective stress granule function. The normal phenotype until 6 months of age can facilitate the study of early pathways underlying ALS.
Introduction
Amyotrophic lateral sclerosis (ALS) is a late onset, rapidly progressive, neurodegenerative disease characterised by degeneration of upper and lower motor neurons leading to weakness, spasticity, paralysis and ultimately death from respiratory failure with a median survival from symptom onset of 30 months (Rowland and Shneider, 2001; Talbot, 2009 ). The majority of ALS cases are not associated with a clear family history (so-called 'sporadic ALS'), and are presumed to be caused by a combination of complex genetic susceptibility, age-dependent stochastic changes in cellular homeostasis, and as yet unidentified environmental factors, in a 'multistep' model (Al-Chalabi et al., 2014) . Approximately 10% of ALS cases are familial (FALS), mostly caused by a single mutation inherited in an autosomal dominant pattern (Da Cruz and Cleveland, 2011) . Mutations in the same genes responsible for FALS are found in a significant minority of clinically indistinguishable SALS cases, suggesting that genetic factors are likely to be relevant to most cases of ALS and the distinction between familial and sporadic ALS is not absolute (Talbot, 2011) .
The common neuropathological marker in over 95% of cases of both sporadic and familial ALS is the redistribution of the protein TDP-43 (43-kDa transactive response DNA-binding protein) from a predominantly nuclear localisation to form insoluble ubiquitinated aggregates in the cytoplasm of affected motor neurons (Arai et al., 2006; Neumann et al., 2006) . TDP-43 is a DNA/RNA-binding protein containing an N-terminal domain, two RNA-recognition motifs and a glycine-rich C-terminal domain thought to be important for mediating protein-protein and protein-RNA interactions, especially with heterogeneous nuclear ribonucleoproteins (hnRNPs). A wide variety of physiological roles for TDP-43 have been identified, including in transcription, translation, splicing, nucleocytoplasmic shuttling, transport for local translation, and in stress granule assembly (Lagier-Tourenne
